New Hope Liuhe (000876.SZ) Earnings Analysis
New Hope Liuhe (000876.SZ) next reports earnings on 2026-08-27, consensus EPS -0.32 CNY. It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -9.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 000876.SZ next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | -0.32 CNY |
| Revenue estimate | 25.63B |
000876.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | -0.2 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.00104 CNY | 0.04 CNY | -97.4% | Miss |
| 2025-06-30 | 0.06278 CNY | n/a | n/a | n/a |
| 2025-04-26 | 0.07078 CNY | -0.29 CNY | +124.4% | Beat |
| 2024-08-30 | 0.1608 CNY | n/a | n/a | n/a |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
000876.SZ valuation and analyst view
| Trailing P/E | -9.75 |
|---|---|
| Trailing EPS | -0.6944 CNY |
| Price / book | 1.54 |
| Dividend yield | 0.35% |
| Market cap | 31.47B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is New Hope Liuhe (000876.SZ)'s next earnings date?
New Hope Liuhe is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.32 CNY and revenue estimate of 25.63B.
Did 000876.SZ beat earnings last quarter?
Consensus estimate data was not available for 000876.SZ's 2026-04-29 report.
What is 000876.SZ's earnings track record?
Over the last 2 reported quarters with consensus data, 000876.SZ beat estimates 1 times (50%).
What is 000876.SZ's current P/E ratio and EPS?
000876.SZ trades at a trailing P/E of -9.75 on trailing EPS of -0.6944043967167265 CNY.
What do analysts rate 000876.SZ?
000876.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.